Unique ID issued by UMIN | UMIN000007109 |
---|---|
Receipt number | R000008373 |
Scientific Title | Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure: AQUAMARINE Study |
Date of disclosure of the study information | 2012/01/23 |
Last modified on | 2015/02/11 18:55:54 |
Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure: AQUAMARINE Study
AQUAMARINE
Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure: AQUAMARINE Study
AQUAMARINE
Japan |
Acute decompensated heart failure
Cardiology |
Others
NO
To investigate the effect of tolvaptan on acute congestive heart failure patients
Safety,Efficacy
Pragmatic
Phase IV
A cumulative urine volume (for 48 hours)
AKI, Cumulative Urine Volume (1-12 hours),additional diuretics dose, serum BUN, serum Cr, eGFR, BNP, serum Na, serum K, NYHA classification,
Dyspnea (rational symptom), Improvement in signs of heart failure, (rales, edema, gallop rhythm) , Duration of hospital stays
Subgroup analysis: Gender, LVEF >=50%, eGFR<60, eGFR<30, BUN>median value, BUN/Cr>median value, SBP>140, SBP<100, Age >=75 years, prescribed furosemide more than 20mg, ischemic etiology, atrial fibrillation
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
Central registration
2
Treatment
Medicine |
Tolvaptan Group : Tolvaptan 15mg orally + Furosemide i.v at least 20mg longer that 2 days
Furosemide i.v at least 20mg longer that 2 days
Not applicable |
85 | years-old | > |
Male and Female
(1) Patients with fluid retention in congestive heart failure
(2) Patients who were hospitalized for acute exacerbation of chronic heart failure
(3) glomerular fi ltration rate [eGFR] of 15–60 mL/min/1•73 m²,
(4) Aged 85 years or younger
(1) Patients with circulatory assist device
(2) Patients with consciousness disturbance
(3) Hypernatremia (serum Na>147mEq/L) (4) Patients with dehydration
(5) Insensitivity to the thirst or difficult for the water intake
(6) Severe hypotension or cardiogenic shock
(7) Patients are considered undesirable rapid decrease in blood flow circulation
(8) Patietns with hypersensitivity to study drug
(9) Anuric patients
(10) Pregnant woman, lactational woman, patients may be willing to be pregnant or are pregnant
(11) In addition, patients were judged as inadequate by physician
(12) Acute myocardial infarction
220
1st name | |
Middle name | |
Last name | Makoto Suzuki |
Kameda Medical Center
Department of Cardiology
929 Higash-cho, Kamogawa City, Chiba
(047)-092-2211
1st name | |
Middle name | |
Last name | Yuya Matsue |
Kameda Medical Center
Department of Cardiology
929 Higash-cho, Kamogawa City, Chiba
(047)-092-2211
yuya8950@gmail.com
Kameda Medical Center
Japanese Heart Foundation
Non profit foundation
Japan
Tokyo Metropolitan Hiroo Hospital, Oume Municipal General Hospital, Social Insurance Chuo General Hospital, Toho-University Ohashi Hospital, Saitama Medical Center, etc.
NO
2012 | Year | 01 | Month | 23 | Day |
http://www.ncbi.nlm.nih.gov/pubmed/24048511
Unpublished
No longer recruiting
2012 | Year | 01 | Month | 04 | Day |
2012 | Year | 01 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2015 | Year | 03 | Month | 01 | Day |
2015 | Year | 03 | Month | 15 | Day |
2015 | Year | 03 | Month | 31 | Day |
2012 | Year | 01 | Month | 20 | Day |
2015 | Year | 02 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008373
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |